Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Gross Profit (2018 - 2025)

Historic Gross Profit for AVITA Medical (RCEL) over the last 8 years, with Q4 2025 value amounting to $14.3 million.

  • AVITA Medical's Gross Profit fell 1125.51% to $14.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $58.8 million, marking a year-over-year increase of 663.38%. This contributed to the annual value of $58.8 million for FY2025, which is 663.38% up from last year.
  • Latest data reveals that AVITA Medical reported Gross Profit of $14.3 million as of Q4 2025, which was down 1125.51% from $13.9 million recorded in Q3 2025.
  • AVITA Medical's 5-year Gross Profit high stood at $16.4 million for Q3 2024, and its period low was $5.8 million during Q1 2022.
  • Over the past 5 years, AVITA Medical's median Gross Profit value was $9.6 million (recorded in 2024), while the average stood at $10.8 million.
  • As far as peak fluctuations go, AVITA Medical's Gross Profit surged by 17475.86% in 2021, and later plummeted by 1577.99% in 2022.
  • Quarter analysis of 5 years shows AVITA Medical's Gross Profit stood at $5.9 million in 2021, then soared by 36.68% to $8.1 million in 2022, then soared by 52.92% to $12.4 million in 2023, then soared by 30.06% to $16.1 million in 2024, then dropped by 11.26% to $14.3 million in 2025.
  • Its Gross Profit stands at $14.3 million for Q4 2025, versus $13.9 million for Q3 2025 and $14.9 million for Q2 2025.